Cover Image

Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review

Jason W Bennett1, James S Lewis II2, Michael W Ellis11Department of Medicine-Infectious Disease Service, Brooke Army Medical Center, Fort Sam Houston, TX, USA; 2Department of Medicine-Division of Infectious Diseases, University of Texas Health Science Center, San Antonio, TX, USAAbstract: Increasing...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jason W Bennett (Author), James S Lewis II (Author), Michael W Ellis (Author)
Format:	Book
Published:	Dove Medical Press, 2008-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dalbavancin in the treatment of skin and soft tissues infection
by: Ana Candela Fajardo, et al.
Published: (2017)

Real-World Use of Dalbavancin for Treatment of Soft Tissue and Bone Infection in Children: Safe, Effective and Hospital-Time Sparing
by: Désirée Caselli, et al.
Published: (2024)

Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs
by: Pedro Luis Gonzalez, et al.
Published: (2018)

Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
by: Leuthner KD, et al.
Published: (2016)

Comparative pharmacoeconomic analysis of ceffaroline fosamil in the treatment of complicated skin and soft tissues infections
by: S. K. Zyryanov, et al.
Published: (2018)

Purulent Skin and Soft Tissue Infection
by: Steven Alexander Kahn MD, et al.
Published: (2010)

In Vitro Activities of Ceftobiprole, Dalbavancin, Tedizolid and Comparators against Clinical Isolates of Methicillin-Resistant <i>Staphylococcus aureus</i> Associated with Skin and Soft Tissue Infections
by: Sofia Maraki, et al.
Published: (2023)

Safety and Efficacy of Dalbavancin in Real Life: Retrospective Analysis of a Large Monocentric Case Series of Patients Treated for Skin/Soft Tissue and Other Difficult-to-Treat Infections
by: Giustino Parruti, et al.
Published: (2024)

New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin
by: Juul JJ, et al.
Published: (2016)

Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular Infections
by: Giacomo Stroffolini, et al.
Published: (2022)

Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia
by: Mpenge MA, et al.
Published: (2015)

Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review
by: Luis Buzón-Martín, et al.
Published: (2021)

A Narrative Review on the Role of Dalbavancin in the Treatment of Bone and Joint Infections
by: Dimitra Dimopoulou, et al.
Published: (2023)

Dalbavancin in Bone and Joint Infections: A Systematic Review
by: Sofia Lovatti, et al.
Published: (2023)

Dalbavancin for Acute Bacterial Skin and Skin Structure Infections in Pediatrics: Insights from Continuation Therapy Experience
by: Sara Maria Scarano, et al.
Published: (2024)

Topical Antiseptic Formulations for Skin and Soft Tissue Infections
by: Thi Phuong Nga Hoang, et al.
Published: (2021)

Impact of Antibiotic Stewardship on Treatment of Hospitalized Children with Skin and Soft-Tissue Infections
by: Giulia Brigadoi, et al.
Published: (2024)

New Antibiotics for the Treatment of Acute Bacterial Skin and Soft Tissue Infections in Pediatrics
by: Nicola Principi, et al.
Published: (2020)

Use of Dalbavancin in Skin, Bone and Joint Infections: A Real-Life Experience in an Italian Center
by: Lucia Brescini, et al.
Published: (2021)

Treatment of purulent complications of soft tissues' gunshot wounds
by: I. P. Khomenkо, et al.
Published: (2017)

Treatment of purulent complications of soft tissues' gunshot wounds
by: I. P. Khomenkо, et al.
Published: (2017)

Expression of Staphylococcal Virulence Genes In Situ in Human Skin and Soft Tissue Infections
by: Michael S. Pulia, et al.
Published: (2022)

Efficacy and Safety of Iclaprim for the Treatment of Skin Structures and Soft Tissue Infections: A Methodological Framework
by: Lian Wang, et al.
Published: (2022)

Skin and Soft Tissue Infections Caused by Mycobacterium chelonae: More Common Than Expected?
by: Ugur Uslu, et al.
Published: (2019)

Purulent Skin and Soft Tissue Infections, Challenging the Practice of Incision and Drainage: A Scoping Review
by: Liam Stout, et al.
Published: (2023)

Evaluating the Use of Dalbavancin for Off-Label Indications
by: Katherine Taylor, et al.
Published: (2022)

Self-care habits among people who inject drugs with skin and soft tissue infections: a qualitative analysis
by: Andrew R. Gilbert, et al.
Published: (2019)

Comparative Evaluation of Existing and Rationally Designed Novel Antimicrobial Peptides for Treatment of Skin and Soft Tissue Infections
by: Anna Ramata-Stunda, et al.
Published: (2023)

Treatment experiences for skin and soft tissue infections among participants of syringe service programs in North Carolina
by: Mary C. Figgatt, et al.
Published: (2021)

Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin
by: Stephens JM, et al.
Published: (2013)

Clinical Impact of <i>Staphylococcus aureus</i> Skin and Soft Tissue Infections
by: Matthew S. Linz, et al.
Published: (2023)

Acute bacterial skin and soft tissue infections: new drugs in ID armamentarium
by: Raghavendra Tirupathi, et al.
Published: (2019)

Successful use of dalbavancin in the treatment of gram positive blood stream infections: a case series
by: Connor Evins, et al.
Published: (2022)

Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis
by: Liu C, et al.
Published: (2016)

Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety
by: Andrés Ruiz-Sancho, et al.
Published: (2023)

Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
by: Leama Ajaka, et al.
Published: (2020)

Review of soft tissue augmentation in the face
by: James Newman
Published: (2009)

The use of extrapolation based on modeling and simulation to support high‐dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft‐tissue infections
by: Phylinda L.S. Chan, et al.
Published: (2021)

Necrotizing Soft Tissue Infection
by: Sahil Aggarwal, BS, et al.
Published: (2018)

Nocardia takedensis: a newly recognized pathogen responsible for skin and soft tissue infections
by: Romain Lotte, et al.
Published: (2020)